Matt Miksic
Stock Analyst at Barclays
(3.21)
# 2,454
Out of 4,455 analysts
807
Total ratings
50.3%
Success rate
1.8%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $96 → $89 | $44.23 | +101.22% | 50 | May 28, 2026 | |
| PODD Insulet | Maintained: Sell | $198 | $158.25 | +25.12% | 20 | May 28, 2026 | |
| DXCM DexCom | Rated: Sell | $67 → $64 | $70.14 | -8.75% | 22 | May 18, 2026 | |
| AVR Anteris Technologies Global | Maintained: Buy | $17 → $18 | $9.69 | +85.76% | 6 | May 15, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $255 | $254.66 | +0.13% | 93 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Rated: Buy | $12 → $13 | $4.24 | +206.60% | 7 | May 13, 2026 | |
| HUMA Humacyte | Rated: Buy | $1.5 | $0.7086 | +111.69% | 4 | May 13, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $202 → $204 | $155.92 | +30.84% | 23 | May 11, 2026 | |
| GMED Globus Medical | Maintained: Buy | $123 | $86.25 | +42.61% | 49 | May 11, 2026 | |
| SENS Senseonics Holdings | Maintained: Buy | $31 | $5.72 | +441.96% | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $55 | $16.24 | +238.67% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $76 | $83.43 | -8.91% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $14.63 | +29.87% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $24 | $9.30 | +158.06% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 72.88 → CHF 63.16 | $55.20 | +14.42% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $22.04 | +22.50% | 41 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $469 → $394 | $332.71 | +18.42% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $16.32 | +22.55% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $78 | $65.76 | +18.61% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 → $94 | $93.10 | +0.97% | 40 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $110 | $90.78 | +21.17% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $712 → $651 | $404.70 | +60.86% | 19 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $144 → $143 | $94.12 | +51.93% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 → $120 | $80.98 | +48.18% | 68 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $14.24 | +82.58% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 | $71.02 | +45.03% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.43 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $722 → $418 | $178.43 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $0.191 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $28 | $17.38 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $67 | $11.01 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $84.95 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $87 | $18.76 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $26.96 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $3.93 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $2.16 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $30.04 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $7.47 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $35.95 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $9.78 | n/a | 3 | Mar 14, 2013 |
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $96 → $89
Current: $44.23
Upside: +101.22%
Insulet
May 28, 2026
Maintained: Sell
Price Target: $198
Current: $158.25
Upside: +25.12%
DexCom
May 18, 2026
Rated: Sell
Price Target: $67 → $64
Current: $70.14
Upside: -8.75%
Anteris Technologies Global
May 15, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $9.69
Upside: +85.76%
Johnson & Johnson
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $254.66
Upside: +0.13%
Orchestra BioMed Holdings
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $4.24
Upside: +206.60%
Humacyte
May 13, 2026
Rated: Buy
Price Target: $1.5
Current: $0.7086
Upside: +111.69%
Becton, Dickinson and Company
May 11, 2026
Rated: Buy
Price Target: $202 → $204
Current: $155.92
Upside: +30.84%
Globus Medical
May 11, 2026
Maintained: Buy
Price Target: $123
Current: $86.25
Upside: +42.61%
Senseonics Holdings
May 11, 2026
Maintained: Buy
Price Target: $31
Current: $5.72
Upside: +441.96%
May 8, 2026
Maintained: Buy
Price Target: $56 → $55
Current: $16.24
Upside: +238.67%
May 7, 2026
Maintained: Hold
Price Target: $73 → $76
Current: $83.43
Upside: -8.91%
May 7, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $14.63
Upside: +29.87%
May 6, 2026
Maintained: Buy
Price Target: $27 → $24
Current: $9.30
Upside: +158.06%
May 6, 2026
Reiterated: Hold
Price Target: CHF 72.88 → CHF 63.16
Current: $55.20
Upside: +14.42%
May 4, 2026
Maintained: Buy
Price Target: $25 → $27
Current: $22.04
Upside: +22.50%
May 1, 2026
Maintained: Buy
Price Target: $469 → $394
Current: $332.71
Upside: +18.42%
Apr 30, 2026
Maintained: Hold
Price Target: $20
Current: $16.32
Upside: +22.55%
Apr 30, 2026
Maintained: Hold
Price Target: $87 → $78
Current: $65.76
Upside: +18.61%
Apr 29, 2026
Maintained: Sell
Price Target: $100 → $94
Current: $93.10
Upside: +0.97%
Apr 24, 2026
Maintained: Buy
Price Target: $104 → $110
Current: $90.78
Upside: +21.17%
Apr 23, 2026
Rated: Buy
Price Target: $712 → $651
Current: $404.70
Upside: +60.86%
Apr 20, 2026
Rated: Buy
Price Target: $144 → $143
Current: $94.12
Upside: +51.93%
Apr 1, 2026
Maintained: Buy
Price Target: $118 → $120
Current: $80.98
Upside: +48.18%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $14.24
Upside: +82.58%
Mar 24, 2026
Reiterated: Buy
Price Target: $103
Current: $71.02
Upside: +45.03%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $2.43
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $722 → $418
Current: $178.43
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $16 → $13
Current: $0.191
Upside: n/a
Mar 2, 2022
Maintained: Buy
Price Target: $31 → $28
Current: $17.38
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $74 → $67
Current: $11.01
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $100
Current: $84.95
Upside: n/a
Nov 3, 2021
Maintained: Buy
Price Target: $79 → $87
Current: $18.76
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $26.96
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $3.93
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $2.16
Upside: n/a
Nov 3, 2014
Maintained: Hold
Price Target: $37
Current: $30.04
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $7.47
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $35.95
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $9.78
Upside: n/a